Unique ID issued by UMIN | UMIN000043154 |
---|---|
Receipt number | R000049260 |
Scientific Title | Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational Study - |
Date of disclosure of the study information | 2021/01/27 |
Last modified on | 2024/01/30 16:23:39 |
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease
- A Prospective Observational Study -
Shizuoka AE-ILD study
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease
- A Prospective Observational Study -
Shizuoka AE-ILD study
Japan |
Acute exacerbation of interstitial lung disease
Medicine in general | Pneumology | Clinical immunology |
Others
NO
To investigate initial treatment and clinical course of acute exacerbations (AE) in patients with interstitial lung disease (ILD)
Others
- To determine the prognosis and prognostic factors of AE-ILD by underlying disease
- To evaluate the efficacy and safety of treatment
Exploratory
Not applicable
Survival rate of AE-ILD by each underlying disease
- 3-month survival rate
- Survival time and cumulative survival rate
- Relapse-free survival rate
- Incidence of adverse events for each treatment
- Changes in symptom scores and various laboratory findings
- Risk factors for death
- Risk factors for relapse or death
- Risk factors for developing infections (e.g., pneumocystis pneumonia)
- Treatment status
- Survival rate by treatment
- Development of new serum biomarkers
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients with ILD who had developed AE for the first time
(1) Patients undergoing chemotherapy, molecular targeted therapy, or immune checkpoint inhibitor therapy for malignancy
(2) Patients with malignancy who are expected to have a prognosis of less than 1 year
(3) Patients who are determined to be inappropriate for this study for other reasons
400
1st name | Suda |
Middle name | |
Last name | Takafumi |
Hamamatsu University School of Medicine
Second Division, Department of Internal Medicine
4313192
1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192 Japan
+81-53-435-2263
suda@hama-med.ac.jp
1st name | Hironao |
Middle name | |
Last name | Hozumi |
Hamamatsu University School of Medicine
Second Division, Department of Internal Medicine
4313192
1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192 Japan
+81-53-435-2263
hozumi@hama-med.ac.jp
Hamamatsu University School of Medicine
Hamamatsu University School of Medicine
Self funding
Iwata City Hospital
Tenryu Hospital
Enshu Hospital
Shizuoka General Hospital
Shizuoka Saiseikai Hospital
Shizuoka City Shizuoka Hospital
Shizuoka City Shimizu Hospital
Shizuoka Red-cross Hospital
Seirei Hamamatsu Hospital
Seirei Mikatahara Hospital
Hamamatsu Rosai Hospital
Hamamatsu Red-cross Hospital
Hamamatsu Medical Center
Fujieda City Hospital
Hamamatsu University School of Medicine
1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192 Japan
+81-53-435-2680
rinri@hama-med.ac.jp
NO
2021 | Year | 01 | Month | 27 | Day |
Unpublished
Open public recruiting
2019 | Year | 11 | Month | 08 | Day |
2019 | Year | 12 | Month | 02 | Day |
2019 | Year | 12 | Month | 02 | Day |
2029 | Year | 11 | Month | 30 | Day |
This is a study to investigate the prognosis and treatment of patients with acute exacerbations of a variety of interstitial lung diseases.
2021 | Year | 01 | Month | 27 | Day |
2024 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049260
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |